The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.
about
Role of microRNAs in islet beta-cell compensation and failure during diabetesInduction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failureEndoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDLAssociation of hematological factors with components of the metabolic syndrome in older and younger adults.PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects.Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome.Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.Relation of circulating oxidized LDL to obesity and insulin resistance in childrenHuman C-reactive protein and the metabolic syndrome.Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts.Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome.Association of inflammatory and oxidative stress markers with metabolic syndrome in asian indians in India.Heterogeneous vascular responses to lifestyle intervention in obese Latino adolescents.Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study.Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis.The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study.LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets.Aging, metabolic syndrome and the heart.Effects of dietary flavonoids intake in saudi patients with coronary heart diseaseMicrovesicles/exosomes as potential novel biomarkers of metabolic diseasesIn vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow CytometryDeterminants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up studyThe 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations.Metabolic syndrome and its association with morbidity and mortality.Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndromeEffects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitusCirculating oxidized LDL and inflammation in extreme pediatric obesity.Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.Oxidized LDL and the metabolic syndromeComparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study.The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.Stress in obesity and associated metabolic and cardiovascular disorders.Abdominal adiposity, insulin resistance, and oxidized low-density lipoproteins in Latino adolescents.The vicious circle between oxidative stress and inflammation in atherosclerosis.Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
P2860
Q26995308-9AF76F62-DCDF-4DB3-A136-B409370EE0C3Q28247437-8C3B3CEC-1D77-4BC9-9A46-1C277296797EQ28554206-D8E5E453-E1AB-472C-9BB9-95A4E95EE671Q33270446-E6386F88-F1C3-4FB2-81D3-082049AB6A44Q33572702-BB587E06-2ACC-4448-B809-CDE6D69FC904Q33576005-3ED0BEE8-1947-4039-BAE7-F503736BDF4EQ33642534-594A71E9-71E8-4024-8C38-BB5EC40C8106Q33749982-40DA2593-1AEE-41FD-8BFD-5015E4FF7217Q33788524-72DB27F4-F0DD-442B-8667-708D937F4C25Q33939600-0FB98A81-991E-4A4D-A7F8-0F63E205A549Q34066540-4A6E3968-329C-4D10-8E76-75A4D2C34463Q34097986-B3B83C00-22DA-4E13-98D0-DA14B5669815Q34137738-1C5C2B42-8BF1-4A3A-89F5-3338E227F6ACQ34479203-E4405419-F87D-4DD9-A0AF-C2B31E1F8E53Q34919390-DF2419BD-B298-4BEF-9782-7F5DB894AB27Q35031319-599B9CED-91FA-462D-AB1C-78B81428E274Q35089511-BDDCC542-B57D-4D4C-BB74-3C0E552B6562Q35395358-7B42C3AB-4230-46AD-897A-F71762D37086Q35717014-83E9F9C7-7F1D-4575-9C19-57FFFE3D4C12Q36008276-AC964A8D-225F-417F-8D30-228A3035A1E7Q36031750-FC6512B9-260F-42BA-A049-07847A774647Q36134270-B1008DBE-7020-4CE7-B78C-941CD970D1B3Q36175435-D02C1723-D515-4E93-85F0-9C665B5D62F3Q36351154-CE4F06CB-F2BB-49F4-AC97-EB02C16E8602Q36487547-2E35F035-824E-484E-9F08-5BCB3E1A6B92Q36712234-5D8E2B1F-01FA-44C7-8521-95A014C6D178Q36749240-323D5FD6-3C0B-44F0-8EC7-1285C4B8CB7CQ36925959-7DB5DB69-5708-4FC8-8018-E47F0862A421Q36930450-A1421D42-8608-462F-9436-C04F93A65D39Q36934347-50E72D48-050B-4ADA-A7FF-152ED8F2D885Q36965617-A93BD321-1969-40D9-B46D-27805ED9D3E7Q37074239-A456AEE8-35A1-45B5-A776-7DE19136AF60Q37074685-99449792-E03E-4B3C-AC9C-9C48FF1DF0ECQ37176779-854FCF53-53C7-463C-9049-94A0AE7047D6Q37214275-4958E683-CD27-4FB1-9739-5020A713D296Q37275296-1828E63F-7802-4FD6-9651-CFE0BFBCAC56Q37288068-98C1A1BD-D49E-4AD4-B579-930A623D052DQ37320421-9A2E546E-FA98-47AB-A160-0D4359807BCBQ37334949-A655FA0D-6119-4BE2-8432-9E565921EDCBQ37355913-4AC42BAC-CC50-4BDC-BBDA-1954F83F07CF
P2860
The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The metabolic syndrome, circul ...... , and body composition cohort.
@en
type
label
The metabolic syndrome, circul ...... , and body composition cohort.
@en
prefLabel
The metabolic syndrome, circul ...... , and body composition cohort.
@en
P2093
P50
P1433
P1476
The metabolic syndrome, circul ...... , and body composition cohort.
@en
P2093
Ann Mertens
Bret Goodpaster
Paul Holvoet
Russell P Tracy
Susan M Rubin
P304
P356
10.2337/DIABETES.53.4.1068
P407
P577
2004-04-01T00:00:00Z